EVOTF (EVOTF) Stock Price & Analysis
EVOTF (EVOTF) rose 0.00% to USD 6.69 as of June 10, 2026 at 02:31 UTC, according to Nexqual real-time market data.
EVOTF last closed at USD 6.69; the session ranged USD 6.49–6.69 on volume of 200 shares. Market capitalization is $1.19B, with a 52-week range of USD 4.73–8.58 (PNK). Source: Nexqual, June 10, 2026 at 02:31 UTC.
Key Statistics (as of June 10, 2026 at 02:31 UTC)
| Price | USD 6.69 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 6.69 |
| Open | USD 6.49 |
| Day Range | USD 6.49 – 6.69 |
| 52-Week Range | USD 4.73 – 8.58 |
| Volume | 200 shares |
| Market Cap | $1.19B |
| Exchange | PNK |
Technical Analysis (EVOTF)
Nexqual's technical model rates EVOTF "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 02:31 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 5.94) |
| MACD | 0.18 (positive) |
Analyst Ratings (EVOTF)
Wall Street analysts rate EVOTF "None", per Nexqual as of June 10, 2026 at 02:31 UTC.
| Consensus Rating | None |
|---|
Earnings (EVOTF)
| Next Earnings Date | 2026-05-06 |
|---|---|
| Revenue Estimate | $175.41M |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Financials & Fundamentals (EVOTF)
| Total Revenue | $745.04M |
|---|---|
| Revenue Growth (YoY) | -21.70% |
| Gross Margin | +10.66% |
| Operating Margin | -29.64% |
| Profit Margin | -26.02% |
| ROE | -24.06% |
| Debt / Equity | 55.38 |
| Current Ratio | 1.68 |
| Total Cash | $444.76M |
| Total Debt | $387.46M |
| Free Cash Flow | $98.59M |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Financial Health Score (EVOTF)
Nexqual rates EVOTF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:31 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Critical — Gross margin 11%, operating -30% |
| Balance Sheet | Solid — $445M cash vs $387M debt, net cash position |
| Cash Flow | Solid — FCF $99M, 13% margin |
| Efficiency | Critical — ROE -24%, ROA -3.1% |
Ownership (EVOTF)
| Insider Ownership | +9.97% |
|---|---|
| Institutional Ownership | +67.42% |
| Shares Outstanding | 177.59M |
| Float | 133.41M |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Leadership (EVOTF)
EVOTF is led by Christian Wojczewski (age 52), CEO & Chairperson of the Management Board, per Nexqual as of June 10, 2026 at 02:31 UTC.
| CEO & Chairperson of the Management Board | Christian Wojczewski (age 52) |
|---|---|
| Chief Scientific Officer & Member of Management Board | Cord Dohrmann (age 61) |
| CFO & Member of Management Board | Claire Hinshelwood |
| COO & Member of Management Board | Ingrid Mller (age 53) |
| Senior Vice President of Programme Management & Clinical Operations | Ian M. Hunneyball (age 75) |
Major Backers & Investors (EVOTF)
Notable institutional backers of EVOTF include Brown Capital Mgmt Mutual Fd.s-Brown Capital Mgmt Intl Small Company F, First TRT Exch-Trd Fd.-First TRT WCM Intl Eqy. ETF, DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT., according to Nexqual as of June 10, 2026 at 02:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Brown Capital Mgmt Mutual Fd.s-Brown Capital Mgmt Intl Small Company F | 2.16% |
| First TRT Exch-Trd Fd.-First TRT WCM Intl Eqy. ETF | 1.1% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.57% |
| HARDING LOEVNER Fd.S INC-Harding Loevner Intl Small Companies PORT. | 0.23% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.24% |
| BlackRock | 0.92% |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IPSEY | Ipsen S.A. | USD 42.27 | ▼ 6.15% |
| BIOVF | SWEDISH ORPHAN BIOVITRUM AB | USD 47.35 | ▼ 1.35% |
| HKMPF | Hikma Pharmaceuticals plc. | USD 19.07 | ▼ 1.14% |
| MKGAF | Merck KGaA | USD 159.71 | ▼ 2.48% |
| GNNDY | GN Store Nord A/S | USD 42.4 | ▼ 3.13% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:31 UTC. This page is informational and not investment advice.